1081.8500 -13.00 (-1.19%)
NSE Jul 10, 2025 15:31 PM
Volume: 38,216
 

1081.85
-1.19%
ICICI Securities Limited
Thyrocare Technologies’ (Thyrocare) outperformance in Q4FY25 was driven by surge in volumes (up 15%) and realisation improvement, partially offset by higher ESOP cost.
Thyrocare Technologies Ltd. has gained 53.35% in the last 3 Months
More from Thyrocare Technologies Ltd.
Recommended